Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
-
- Julio Rosenstock
- Dallas Diabetes Research Center at Medical City, Dallas, Texas
-
- Vlado Perkovic
- George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia
-
- Odd Erik Johansen
- Boehringer Ingelheim Norway KS, Asker, Norway
-
- Mark E. Cooper
- Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia
-
- Steven E. Kahn
- Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle
-
- Nikolaus Marx
- Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Germany
-
- John H. Alexander
- Duke Clinical Research Institute, Duke Health, Durham, North Carolina
-
- Michael Pencina
- Duke Clinical Research Institute, Duke Health, Durham, North Carolina
-
- Robert D. Toto
- University of Texas Southwestern Medical Center, Dallas
-
- Christoph Wanner
- Division of Nephrology, Department of Medicine, Würzburg University Clinic, Würzburg, Germany
-
- Bernard Zinman
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
-
- Hans Juergen Woerle
- Ulm University, Ulm, Germany
-
- David Baanstra
- Boehringer Ingelheim, Alkmaar, the Netherlands
-
- Egon Pfarr
- Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
-
- Sven Schnaidt
- Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
-
- Thomas Meinicke
- Boehringer Ingelheim International GmbH, Biberach, Germany
-
- Jyothis T. George
- Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
-
- Maximilian von Eynatten
- Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
-
- Darren K. McGuire
- University of Texas Southwestern Medical Center, Dallas
Bibliographic Information
- Other Title
-
- The CARMELINA Randomized Clinical Trial
Journal
-
- JAMA
-
JAMA 321 (1), 69-, 2019-01-01
American Medical Association (AMA)
- Tweet
Details 詳細情報について
-
- CRID
- 1364233269542328448
-
- ISSN
- 00987484
-
- Data Source
-
- Crossref